These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3519242)

  • 1. Bromocriptine in the treatment of hypertension.
    Walden RJ; Hernandez J; Bhattacharjee P; Graham B; Prichard BN
    Eur J Clin Pharmacol; 1986; 30(2):141-4. PubMed ID: 3519242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of bromocriptine in methyldopa treated hypertension.
    Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients.
    Degli Esposti E; Sturani A; Santoro A; Zuccalà A; Chiarini C; Zucchelli P
    Clin Sci (Lond); 1985 Jul; 69(1):51-6. PubMed ID: 3905210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bromocriptine on arterial blood pressure and serum prolactin level in patients with essential arterial hypertension].
    Hudziak G; Kuska J
    Kardiol Pol; 1988; 31 Suppl 1():22-9. PubMed ID: 3221620
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of distress in hyperprolactinemia with bromocriptine.
    Buckman MT; Kellner R
    Am J Psychiatry; 1985 Feb; 142(2):242-4. PubMed ID: 3882004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
    Stumpe KO; Kolloch R; Higuchi M; Krück F; Vetter H
    Lancet; 1977 Jul; 2(8031):211-4. PubMed ID: 69827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension.
    Sowers JR; Nyby M; Jasberg K
    Hypertension; 1982; 4(3):431-7. PubMed ID: 7068198
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine treatment of the premenstrual syndrome.
    Kullander S; Svanberg L
    Acta Obstet Gynecol Scand; 1979; 58(4):375-8. PubMed ID: 393053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
    Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J
    Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.
    Parlati E; Polinari U; Salvi G; Giorlandino C; Liberale I; Fiorella G; Dell'Acqua S
    Acta Obstet Gynecol Scand; 1987; 66(6):483-8. PubMed ID: 3321867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative bromocriptine adjuvant treatment for operable breast cancer.
    Fentiman IS; Brame K; Chaudary MA; Camplejohn RS; Wang DY; Millis RR
    Lancet; 1988 Mar; 1(8586):609-10. PubMed ID: 2894547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial.
    Wright CS; Steele SJ; Jacobs HS
    Br Med J; 1979 Apr; 1(6170):1037-9. PubMed ID: 376036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD
    Am J Med; 1986 May; 80(5B):29-34. PubMed ID: 2872804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine in the treatment of essential hypertension.
    Gavras I; Gavras H
    J Clin Pharmacol; 1985 Sep; 25(6):429-32. PubMed ID: 3902911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
    Mansel RE; Preece PE; Hughes LE
    Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.